Niche would never have launched rival drug, Servier tells EU court
Niche had never been in a position to sell a copycat hypertension drug, Servier told EU judges today, arguing that a patent settlement deal between the two pharmaceutical companies couldn't be...To view the full article, register now.
Already a subscriber? Click here to view full article